Showing results (2581-2590 of 6,517) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|October 9, 2025
Intratumoral B cell and interferon signatures in newly diagnosed glioblastoma are associated with longer survival in patients treated with SurVaxMHenry G Withers, Sheila A Figel, Jingxin Qiu, et al.Cancer Immunology, Immunotherapy : CII|October 6, 2025
Tumor-draining lymph nodes respond to immune checkpoint inhibition and orchestrate tumor immune remodelingJinzhu Zhang, Jian Ma, Yaru Niu, et al.Cancer Immunology, Immunotherapy : CII|November 3, 2025
The impact of tislelizumab immunotherapy on multiple primary lung cancer presenting as ground-glass nodules: preliminary results analysis from a single-arm, phase II trialJunfei Wu, Xiangning Fu, Yi Gao, et al.Cancer Immunology, Immunotherapy : CII|November 3, 2025
Increased CD103-CD8+ TILs with TPEX phenotype replenish anti-tumor T cell pool in mismatch repair-proficient CRCJinsheng Liu, Jintao Zeng, Ting Zhou, et al.Cancer Immunology, Immunotherapy : CII|November 3, 2025
Ki-67 expression stratifies PD-L1-high NSCLC for immune checkpoint inhibitor plus chemotherapy: a real-world biomarker validationNing Yang, Xiting Chen, Haoqiang Wang, et al.Cancer Immunology, Immunotherapy : CII|November 3, 2025
The immunophenotype of immune checkpoint-induced bullous pemphigoid: a cohort studyNada Saffuri, Ilanit Boyango, Itay Cohen, et al.Cancer Immunology, Immunotherapy : CII|October 23, 2025
Assessment of tertiary lymphoid structures via 18F-FDG PET/CT scan in patients with pancreatic adenocarcinomaYu Yan, Xuan Zou, Xuan Lin, et al.Cancer Immunology, Immunotherapy : CII|October 21, 2025
NKG2D CAR-NK adoptive cellular immunotherapy combined with or without PD-1 blockade in the treatment of patients with metastatic colorectal cancer: an exploratory studyDanyang Wang, Bin Li, Guojie Shen, et al.Cancer Immunology, Immunotherapy : CII|September 30, 2025
Immune checkpoint inhibitors-associated acute kidney injury: a systematic review and meta-analysis of incidence, kidney recovery, and recurrent riskCheng-Wei Ho, Nai-Wen Kang, Tzu-Hsuan Yeh, et al.Cancer Immunology, Immunotherapy : CII|September 29, 2025
Spatially resolved endothelial signaling via nampt-itga5 drives immune evasion in stem-like gastric cancerJi-Yong Sung, Jae-Ho Cheong, Eui Tae KimPageof 652